Active Ingredient History

  • Now
Abediterol is a once-daily experimental drug candidate for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is currently under development by the Spanish pharmaceutical company Almirall and is in Phase II clinical trials.   Wikipedia

  • SMILES: O[C@@H](CNCCCCCCOCC(F)(F)c1ccccc1)c2ccc(O)c3NC(=O)C=Cc23
  • Mol. Mass: 460.52
  • ALogP: 4.23
  • ChEMBL Molecule:
More Chemistry
5-(2-((6-(2,2-difluoro-2-phenylethoxy)hexyl)amino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one | abediterol | las100977 | las-100977


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue